Publication | Closed Access

Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer's disease mouse model

Cannabis UseAlzheimer's DiseaseMedicineDementiaDisease Mouse ModelNeuropharmacologyNeurochemical BiomarkersNeuroscienceNeurologyNeurodegenerationBrain PathologyDeficiency ResultsPharmacologyNeurochemistryCannabinoid Receptor 2Lewy Body Dementia